DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

Phase 2

Completed

Conditions: HIV Infections
Opiate Dependence

Interventions: Behavioral: Standard Sexual Risk Management
Behavioral: Enhanced Sexual Risk Management

First Posted Date: 2007-10-23

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT00548275

Locations: 🇺🇸
Methadone Research Unit, The APT Foundation, Inc., New Haven, Connecticut, United States
🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

Phase 2

Terminated

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: placebo
Drug: N-Acetylcysteine

First Posted Date: 2007-10-04

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT00539513

N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD

Phase 2

Terminated

Conditions: Self-Injurious Behavior
Borderline Personality Disorder

Interventions: Drug: placebo
Drug: N-Acetylcysteine

First Posted Date: 2007-10-04

Last Posted Date: 2020-04-15

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT00539188

Locations: 🇺🇸
Yale OCD Research Clinic, New Haven, Connecticut, United States

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Not Applicable

Completed

Conditions: Opiate Dependence

Interventions: Behavioral: abstinence-contingent buprenorphine (ACB)
Behavioral: behavioral drug and HIV risk reduction counseling (BDRC)

First Posted Date: 2007-10-04

Last Posted Date: 2021-06-18

Lead Sponsor: Yale University

Target Recruit Count: 234

Registration Number: NCT00539123

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇲🇾
Substance Abuse Research Center, Muar, Johor, Malaysia

Treatment for Obesity and Binge Eating Disorder

Not Applicable

Completed

Conditions: Obesity
Binge Eating Disorder

Interventions: Behavioral: CBT and BWL
Behavioral: Behavioral Weight Loss Treatment
Behavioral: Cognitive Behavior Therapy

First Posted Date: 2007-10-01

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 125

Registration Number: NCT00537758

Locations: 🇺🇸
Yale Psychiatric Research at Congress Place, New Haven, Connecticut, United States

Treatment of Binge Eating in Obese Patients in Primary Care

Phase 4

Completed

Conditions: Binge Eating
Obesity

Interventions: Drug: Placebo
Behavioral: Self-help CBT + Sibutramine
Behavioral: Self-help CBT + Placebo
Drug: Sibutramine

First Posted Date: 2007-10-01

Last Posted Date: 2021-08-18

Lead Sponsor: Yale University

Target Recruit Count: 104

Registration Number: NCT00537810

Locations: 🇺🇸
Yale-New Haven Hospital (YNHH) Primary Care Center (PCC), New Haven, Connecticut, United States
🇺🇸
Yale Internal Medicine Associates (YIMA), New Haven, Connecticut, United States
🇺🇸
Yale Psychiatric Research at Congress Place, New Haven, Connecticut, United States

Clinical Trial of Abstinence-Linked Money Management

Phase 2

Completed

Conditions: Substance Abuse

Interventions: Behavioral: FIT
Behavioral: Advisor-Teller Money Manager

First Posted Date: 2007-09-28

Last Posted Date: 2020-03-30

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT00536900

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth

Completed

Conditions: Impaired Glucose Tolerance
Childhood Obesity
Pre-diabetes
Insulin Resistance
Metabolic Syndrome

First Posted Date: 2007-09-27

Last Posted Date: 2018-01-18

Lead Sponsor: Yale University

Target Recruit Count: 255

Registration Number: NCT00536250

Locations: 🇺🇸
47 College Street, New Haven, Connecticut, United States

Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder

Phase 4

Completed

Conditions: Premenstrual Dysphoric Disorder

Interventions: Drug: Sertraline
Drug: Placebo

First Posted Date: 2007-09-27

Last Posted Date: 2017-04-14

Lead Sponsor: Yale University

Target Recruit Count: 252

Registration Number: NCT00536198

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
Cornell University, Weill Medical College, New York, New York, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome

Phase 2

Completed

Conditions: Tourette Syndrome

Interventions: Device: Transcranial Magnetic Stimulation (sham)
Device: Transcranial Magnetic Stimulation (active)

First Posted Date: 2007-09-14

Last Posted Date: 2019-02-21

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT00529308

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy